30 closest matches · ranked by relevance
Serum CNP Levels · Healthy Reproductive Age Women · Healthy Perimenopausal Women
Primary: Serum C Type Natriuretic Peptide Levels — 43.68; 55.98; 116.36 pg/ml — p=<0.017
Polycystic Ovary Syndrome · c Type Natriuretic Peptide · Menstrual Irregularity
Primary: Serum CNP Levels of PCOS and Healthy Participants — 110; 57 pg/ml — p=0.004
Congenital Heart Disease · Cardiovascular Disease
Primary: BNP Levels — 16.3; 42.4; 384.3 pg/ml
Left Ventricular Diastolic Dysfunction
Primary: Change in Urinary Sodium Excretion in Response to Saline Load — 381.6; -10.5 mEq/minute — p=<0.001
Heart Failure · Asymptomatic Systolic Dysfunction
Primary: Change in Urinary Sodium Excretion in Response to Saline Load — 179.1; 3.1 mEq/min — p=<0.05
Healthy · Lean
Primary: Changes in NT-proANP From Baseline to 8 Hours — -0.33 nmol/l
Congestive Heart Failure
Primary: Change in Natriuresis (Urinary Sodium Excretion) in Control Subjects at 60 Minutes After Volume Expansion Compared to Baseline in Response to Placebo Treatment — 87.19…
SIRS · Sepsis · Shock
Primary: Pattern of NT-proBNP, Biomarkers and Surface Markers on Leukocytes — 902; 4,429 pg/ml
Surgery
Primary: Occurence of Adverse Cardiac Events — 91 participants
Fluid Overload · Fluid Loss · Volume Overload
Primary: Number of Patients With Pro-ANP Twofold Raise by the End of Surgery — 17 Participants
Breast Cancer
Primary: Pre-operative Concentration of NT-proBNP — 38.9; 32.2 pg/ml — p=0.714
Congestive Heart Failure · Cardiomyopathy
Primary: Change in Left Ventricular (LV) Volume Index at 8 Weeks — -5.2; 5.8; -10.0; 6.1 ml/m^2 — p=0.004
Heart Failure With Preserved Ejection Fraction
Primary: Change in Plasma N-terminal Proatrial Natriuretic Peptide (NT proANP) — 47.4; 46.4 pg/mL
Natriuretic Peptides · Obesity · Nocturnal Blood Pressure
Primary: Plasma MRproANP — 17.92; 15.51 pmol/l — p=0.003
Chronic Heart Failure
Primary: Natriuretic Brain Pro-peptid — 312; 200 pg/ml
Chronic Heart Failure (CHF)
Primary: Number of Clinically Stable Patients Whose Therapy Regimen Adheres to ESC Guideline Recommendations for Drug Types (Level 1) and Drug Type and Dose (Level 2) at Visit 1…
Fluid Over-load
Primary: Length of Stay — 4; 6 days
Alzheimer's Disease
Primary: Number of Subjects With Non-serious and Serious Adverse Events (AEs) and Deaths — 18; 19; 22; 20 Participants
Healthy · Natriuretic Peptides · Metabolic Syndrome
Primary: Plasma MRproANP — 23 Percentage of change
Achondroplasia
Primary: Annualized Height Velocity (cm/Year) After 52 Weeks of Double-blind Treatment — 4.09; 4.52; 5.16; 5.42 cm/year — p== 0.6004
Acute Heart Failure
Primary: N-terminal Pro-brain Natriuretic Peptide (NT-proBNP) Values and Time-averaged Change From Baseline — 0.7466; 0.5333 pg/ml — p=<.0001
Bariatric Surgery
Primary: The Absolute Difference in Mean Arterial Pressure Between the Arterial Catheter and the CNAP. — 7.7 mmHg
Chronic Heart Failure
Primary: Change From Baseline in N-terminal Pro-brain Natriuretic Peptide (NT-proBNP) — 0.83; 1.08 ratio: endpoint/baseline (pg/mL)
Congestive Heart Failure
Primary: Change in Natriuresis (Urinary Sodium Excretion) at 60 Minutes for Preclinical Systolic Dysfunction (PSD) Reporting Group — 41.8; 88.9 mEq/min — p=0.26
Stable Angina
Primary: Biomarker Titer of Patients With Coronary Artery Disease — 13; 5; 60; 0.5 tilter — p=0.002
Acute Decompensated Heart Failure
Primary: Renal Function by Serum Creatinine — 1.3; 1.3; 1.3; 1.4 mg/dL
Hypertension · Left Ventricular Hypertrophy
Primary: Percent Change of B Type Natriuretic Peptides (BNP) Level — -29.2 Percent Change
Mood Disorder · Anxiety Disorders
Primary: Levels of NPY in CSF — 329.4; 351.0 pg/mL
Healthy · Pre Hypertension
Primary: Change in Plasma BNP After 6-weeks of Beta-Blocker — 45; 74 Percentage Change in Plasma BNP levels
Obesity
Primary: Adipose Tissue Gene Expression of UCP1 (Uncoupling Protein 1)- Differences by Obesity Status — 7.79; 24.33 fold change — p=<0.01